GNAS and hepatocellular carcinoma: We focused on early-stage HCC patients and targeted the sera and tissues from early-stage HCC patients and for the first time revealed the correlation between the elevated anti-GNAS autoantibody and the high level of its target protein in stage I HCC patients.